Esketamine pretreatment during cesarean section reduced the incidence of postpartum depression: a randomized controlled trail
Abstract Background Postpartum depression (PPD) is a common mental disease in postpartum women, which has received more and more attention in society. Ketamine has been confirmed for its rapid antidepressant effect in women with PPD. We speculate that esketamine, an enantiomer of ketamine, pretreatm...
Main Authors: | Shixia Xu, Jiaojiao Yang, Jing Li, Min Zhang, Jie Sun, Qingren Liu, Jianjun Yang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2024-01-01
|
Series: | BMC Anesthesiology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12871-023-02398-1 |
Similar Items
-
Efficacy of esketamine for the treatment of postpartum depression and pain control following cesarean section: a randomized, double-blind, controlled clinical trial
by: Shurong Li, et al.
Published: (2024-02-01) -
Analgesic Effect of Esketamine Combined with Tramadol for Patient-Controlled Intravenous Analgesia After Cesarean Section: A Randomized Controlled Trial
by: Guo Y, et al.
Published: (2023-10-01) -
Factors Associated with Primary Postpartum Hemorrhage in Elderly Women Undergoing Repeated Cesarean Deliveries
by: Yang Y, et al.
Published: (2021-12-01) -
Epidural esketamine and morphine for postoperative analgesia after caesarean delivery: A pilot study
by: Ju Tang, et al.
Published: (2023-01-01) -
Neonatal outcomes when intravenous esketamine is added to the parturients transferred from labor analgesia to emergency cesarean section: a retrospective analysis report
by: Zhaojia Liang, et al.
Published: (2023-05-01)